A Studypain relief and assess recovery using intravenous Lignocaine in Laparoscopic Surgeries.
Phase 1
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2020/07/026750
- Lead Sponsor
- ita Dsouza
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1 or 2,
elective laparoscopic surgeries,
duration of surgery of 2 hours,
elective laparoscopic surgeries,
BMI 18-26.
Exclusion Criteria
Patient refusal,
pregnant females
known allergy to study drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)to evaluate the analgesic efficacy of intra-operatively lignocaine infused patients, effectiveness of lignocaine infusion on pressor response at intubation and extubation 2) the effect of intravenous lignocaine on post-operative analgesiaTimepoint: 0, 2, 4, 6, 12, 18, 24 hours
- Secondary Outcome Measures
Name Time Method 1)any side effects of intravenous lidocaine infusions, <br/ ><br>2)the role of i.v. lignocaine on return of bowel movements postoperatively <br/ ><br>3)and its effect on the time to discharge from the hospitalTimepoint: 0,2,4,6,12,18, 24 hours observation for the above